H

ello, everyone, and how are you today? We are just fine, thank you, especially now that the short person has successfully landed at the local schoolhouse for another day of learning. As for us, we are busy quaffing cups of stimulation — cinnamon dolce is on tap this morning — and foraging for tidbits. Busy is good, as they say. Speaking of which, here are some items of interest. Hope your day is simply smashing, and, of course, do keep us in mind when you hear something notable. We accept secrets and documents with open arms …

Federal prosecutors in Connecticut opened a criminal investigation into Purdue Pharma and its marketing of OxyContin, Bloomberg News reports. U.S. Attorney Deirdre Daly is gathering documents about Purdue’s claim that OxyContin provides 12 hours of pain relief. A Los Angeles Times investigation found Purdue ignored evidence showing the drug failed to last that long in some patients, increasing the risk of withdrawal, abuse, and addiction.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • This OTC Narcan deal will go over like flatus in a spacesuit. The only people that will buy the stuff are those with a legitimate pain pill prescription. What addict on smack or fentanyl would, in his right mind walk into Walgreens and buy Narcan OTC. This will be easy to cross check that the junkie has no Rx for pain pill, and it is as good as putting a trail of breadcrumbs right to the drug enforcement authorities, who WILL figure out a way to get this information.

    Good PR, that’s it.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.